United Kingdom Lung Cancer Therapeutics Market, Competition, Forecast and Opportunities, 2018-2028

By Cancer Cell Type (Non-small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC)), By Treatment (Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy, Other Treatments), By Region, Competition Forecast & Opportunities, 2018-2028F

Published	Pages	Publisher	Report code
Oct 2023	82	TechSci Research	ASDR-638107

Published: Oct 2023 - Pages : 82 - Publisher : TechSci Research - Report code : ASDR-638107

1. Johnson & Johnson
2. Boehringer Ingelheim International GmbH.
3. Novartis AG
4. Amgen Inc
5. Bayer AG
6. AstraZeneca
7. Pfizer Inc.
8. Teva Pharmaceutical Industries Ltd.
9. Merck & Co
10. GlaxoSmithKline plc

United Kingdom Lung Cancer Therapeutics Market, Competition, Forecast and Opportunities, 2018-2028

By Cancer Cell Type (Non-small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC)), By Treatment (Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy, Other Treatments), By Region, Competition Forecast & Opportunities, 2018-2028F

How can I help you?

Purchase this report

This report can be of interest as well:

Cancer Immunotherapy: Technologies and Global Markets

Cancer (Oncology) Market Research

United Kingdom Lung Cancer Therapeutics Market, Competition, Forecast and Opportunities, 2018-2028

By Cancer Cell Type (Non-small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC)), By Treatment (Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy, Other Treatments), By Region, Competition Forecast & Opportunities, 2018-2028F

How can I help you?

Purchase this report

This report can be of interest as well:

Cancer Immunotherapy: Technologies and Global Markets